Huma Qamar
About Huma Qamar
Huma Qamar is a seasoned Chief Medical Officer with extensive experience in clinical research across multiple Ivy League institutions and diverse therapeutic areas.
Huma Qamar's Professional Title and Role
Huma Qamar serves as the Chief Medical Officer. In this capacity, she brings her extensive expertise in clinical research, developed through years of working at prestigious Ivy League institutions like Yale University, Harvard University, and the University of Pennsylvania. Her role involves overseeing various medical and clinical aspects, ensuring adherence to FDA inspections, and managing medical affairs teams.
Huma Qamar's Education and Expertise
Huma Qamar holds degrees of MD (Doctor of Medicine), MPH (Master of Public Health), and CMI (Certified Medical Inspector). Her robust academic background complements her extensive experience in clinical research and therapeutic areas. This educational foundation has been pivotal in her successful career, enabling her to excel in developing and executing Phase I-IV clinical protocols, handling FDA inspections, and conducting compliance audits.
Huma Qamar's Background in Clinical Research
Huma Qamar has garnered significant experience in the clinical research field. She has played a crucial role in renowned Ivy League institutions such as Yale University, Harvard University, and the University of Pennsylvania. Her background includes comprehensive knowledge in developing Phase I-IV clinical protocols, executing clinical studies, and navigating FDA inspections. Her expertise spans multiple therapeutic areas, including gene and cell therapy, vaccines, oncology, rheumatology, dermatology, neurology, cardiology, hepatology, and infectious diseases.
Huma Qamar's Leadership in Clinical Development and Operations
As a former VP, Head of Clinical Development & Clinical Operations, Huma Qamar was instrumental in overseeing critical Vaccine and Phase 1/2 Retinitis Pigmentosa trials. Her leadership was vital in driving these complex projects to success. This role showcased her ability to manage large-scale clinical trials and ensure rigorous compliance with regulatory standards, further solidifying her reputation in the clinical research community.
Huma Qamar's Role at Medicus Pharma Ltd
Huma Qamar recently served as the Chief Scientific Officer & Head of R&D Program at Medicus Pharma Ltd. In this role, she led the research and development initiatives of the company, ensuring the successful execution of clinical studies and the development of new therapeutic strategies. Her contributions significantly advanced the company's scientific programs and demonstrated her expertise in managing R&D activities.